Actithera Adds CEO and Board Chair Before Clinical Entry

Evidence Company disclosure · Discovery September 10, 2026 · Importance 3/5 · Direction Neutral Summary Actithera appointed Steven Kelly as chief executive officer and a director, named Briggs Morrison board chair, and added John Crowley as an independent director. Founder Andreas Goutopoulos will continue as…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *